58,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
29 °P sammeln
  • Broschiertes Buch

This book offers an in-depth examination of legal frameworks governing pharmaceutical transactions, product safety, and liability across different jurisdictions. The book analyzes the intersection between contractual obligations, tort-based liability, and public health regulations in the life sciences sector. It explores key issues such as clinical trial agreements, drug manufacturing contracts, patient safety, and compliance with international regulatory bodies like the EMA and FDA. Comparative insights from European, American, and Asian legal systems highlight variations in risk allocation,…mehr

Produktbeschreibung
This book offers an in-depth examination of legal frameworks governing pharmaceutical transactions, product safety, and liability across different jurisdictions. The book analyzes the intersection between contractual obligations, tort-based liability, and public health regulations in the life sciences sector. It explores key issues such as clinical trial agreements, drug manufacturing contracts, patient safety, and compliance with international regulatory bodies like the EMA and FDA. Comparative insights from European, American, and Asian legal systems highlight variations in risk allocation, consumer protection, and corporate accountability. This comprehensive volume serves as a critical reference for legal scholars, policymakers, and pharmaceutical professionals seeking to navigate the complex balance between innovation, ethics, and legal responsibility in global healthcare law.
Autorenporträt
Zahra Babaei Darani, M.A. in Medical Law from Islamic Azad University, researches the legal and ethical aspects of AI in medicine, with a focus on medical and pharmaceutical law.Seyed Mohammad Sadegh Kazemi Shariat Panahi, M.A. in Medical Law, and a lawyer (ICBAR), specializes in contract, sports, medical, and pharmaceutical law.